Translational control of growth factor and proto-oncogene expression

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 1, 1999, Pages 73-86

  Willis, Anne E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

5'Untranslated region; Internal ribosome entry segment; Translational regulation; Upstream open reading frame

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; INITIATION FACTOR; MESSENGER RNA;

CARCINOGENESIS; CELL TRANSFORMATION; GENE EXPRESSION; NONHUMAN; OPEN READING FRAME; PROTEIN SYNTHESIS; PROTO ONCOGENE; REVIEW; RIBOSOME; RNA TRANSLATION;

5' UNTRANSLATED REGIONS; ANIMALS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MOS; GROWTH SUBSTANCES; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENES; RIBOSOMES; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032967120     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00133-2     Document Type: Review

References (77)

1. C.G. Proud, Turned on by insulin, Nature 371 (1994) 747-748.
2. E.J. Brown, S.L. Schreiber, A signalling pathway to translational control, Cell 86 (1996) 517-520.
3. M. Kozak, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs, Nucl. Acids Res. 15 (1987) 8125-8137.
4. M. Kozak, An analysis of vertebrate mRNA sequences: intimations of translation control, J. Cell Biol. 115 (1991) 887-903.
5. J.W. Hershey, Translational control in mammalian cells, Ann. Rev. Biochem. 60 (1991) 717-755.
6. N.K. Gray, M.W. Hentze, Regulation of protein synthesis by mRNA structure, Mol. Biol. Rep. 19 (1994) 195-200.
7. A.P. Geballe, D.R. Morris, Initiation codons within 5′-leaders of mRNAs as regulators of translation, Trends Biochem. Sci. 19 (1994) 159-164.
8. R.J. Jackson, S.L. Hunt, C.L. Gibbs, A. Kaminski, Internal initiation of translation of picornavirus RNAs, Mol. Biol. Reports 19 (1994) 147-159.
9. R.J. Jackson, S.L. Hunt, J.E. Reynolds, A. Kaminski, Cap-dependent and cap-independent transaltion: Operational distinctions and mechanistic interpretations, Curr. Top. Microbiol. Immunol. 203 (1995) 1-29.
10. R.J. Jackson, A. Kaminski, Internal initiation of translation in eukaryotes: The picornavirus paradigm and beyond, RNA 1 (1995) 985-1000.
11. F.S. Leach, T. Tokino, P. Metzler, M. Burrell, J.D. Oliner, S. Smith, D.E. Hill, B. Vogelstein, p53 mutation and MDM2 amplification in human soft tissue sarcomas, Cancer Res. 53 (1993) 2231-2234.
12. C. Cordon-Cardo, E. Latres, M. Drobnjak, M.R. Oliva, D. Pollack, J.M. Woodruff, V. Marchel, A. Levine, Molecular abnormalities of MDM2 and p53 genes in adult soft tissue sarcomas, Cancer Res. 54 (1994) 794-799.
13. J. Momand, G.P. Zambetti, D.C. Olson, D. George, A.J. Levine, The MDM2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell 69 (1992) 1237-1245.
14. J. Piette, H. Neel, V. Maréchal, Mdm2: keeping p53 under control, Oncogene 15 (1997) 1001-1010.
15. J.E. Landers, S.L. Cassel, D.L. George, Translational enhancement of mdm2 oncogene expression in human tumour cells containing a stabilized wild-type p53 protein, Cancer Res. 557 (1997) 3562-3568.
16. K. Lundgren, R. Montes de Ocal Luna, Y.B. McNeill, E.P. Emerick, B. Spencer, C.R. Barfield, G. Lozano, M.P. Rosenberg, C.A. Finlay, Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53, Genes Dev. 11 (1997) 714-725.
17. J.E. Landers, D.S. Haines, J.F. Strauss, D.L. George, Enhanced translation: A novel mechanism of mdm2 overexpression identified in human tumour cell lines, Oncogene 9 (1994) 2745-2750.
18. M. Cross, T.M. Dexter, Growth factors in development, transformation, and tumorigenesis, Cell 64 (1991) 271-280.
19. S.J. Kim, J.H. Kehrl, J. Burton, C.L. Tendler, A.B. Roberts, J. Biol. Chem. 264 (1989) 402-408.
20. S.J. Kim, K. Park, D. Koellers, K.Y. Kim, L.M. Wakefield, M.B. Sporn, A.B. Roberts, Post-transcriptional regulation of the human transforming growth factor-1 gene, J. Biol. Chem. 267 (1992) 13702-13707.
21. M.A. O'Reilly, A.G. Geiser, S.J. Kim, L.A. Bruggeman, A.X. Luu, A.B. Roberts, M.B. Spron, Identification of an activating transcription factor binding site in the human transforming growth factor beta-2 promoter, J. Biol. Chem. 267 (1992) 19938-19942.
22. B.A. Arrick, A.L. Lee, R.L. Grendell, R. Dernyck, Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5′ UTR, Mol. Cell. Biol. 11 (1991) 4306-43314.
23. A.E. Koromilas, A. Lazaris-Karatzas, N. Sonenberg, mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E, EMBO J. 11 (1991) 4153-4158.
24. A. De Benedetti, R.E. Rhoads, Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology, Proc. Natl. Acad. Sci. USA 87 (1990) 8212-8216.
25. C. Kevil, P. Carter, B. Hu, A. DeBenedetti, Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilisation of CUG and AUG codons for translation initiation, Oncogene 11 (1995) 2339-2348.
26. C.A. Nathan, P. Carter, L. Liu, B.D. Li, F. Abreo, A. Tudor, S.G. Zimmer, A. DeBenedetti, Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas, Oncogene 15 (1997) 1087-1094.
27. Y. Tsujimoto, J. Cossman, E. Jafte, C.M. Croce, Involvement of the BC2-2 gene in human follicular lymphoma, Science 228 (1985) 1440-1443.
28. M. Bronner, C. Culin, J. Reed, E. Furth, Bcl-2 protooncogene and the gastrointestinal mucosal epithelial tumour progression model as related to proposed morphologic and molecular oncogenetic sequences, Am. J. Pathol. 146 (1994) 20-26.
29. F. Pezzella, H. Turley, I. Kuzu, M.F. Tungekar, M.S. Dunnill, C.B. Pierce, A. Harris, K.C. Gatter, D.Y. Mason, Bcl-2 protein in non-small-cell lung-carcinoma, New Engl. J. Med. 329 (10) (1993) 690-694.
30. M. Seto, V. Jaeger, R.D. Hockett, W. Grainger, S. Bennet, P. Goldman, S.J. Karsineyer, Embo J. 7 (1988) 123-131.
31. T.M. Miyashita, M. Harigai, M. Hanada, J.C. Reed, Identification of a P53-dependent negative response element in the BC2-2 gene, Cancer Res. 54 (1994) 313-315.
32. M. Harigai, M. Masayoshi, T. Miyashita, M. Hanada, J.C. Reed, A cis-acting element in the BCL-2 gene controls expression through translational mechanisms, Oncogene 12 (1996) 1369-1374.
33. S. Tanaka, D.C. Louie, A. Kant, J.C. Reed, Application of a PCR-mismatch technique to the BCL-2 gene-detection of a point mutation in BCL-2 malignancies with a t(14;18) chromosomal translocation, Blood 79 (1992) 229-334.
34. S.A. Maxwell, R.B. Arlinghaus, Serine kinase activity associated with moloney murine virus-124 encoded p37 mos, Virology 143 (1985) 321-333.
35. N. Yew, M. Strobel, G.F. Vande Woude, Mos and the cell cycle: the molecular basis of the transformed phenotype, Curr. Opin. Genet. Dev. 3 (1993) 19-25.
36. F. Propst, M.P. Rosenberg, A. Iyer, K. Kaul, G.F. Vande Woude, c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation and localization in specific cell types, Mol. Cell. Biol. 7 (1993) 1629-1637.
37. G.L. Mutter, D.J. Wolgemuth, Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells, Proc. Natl. Acad. Sci. USA 84 (1987) 5301-5305.
38. L.F. Steel, D.L. Telly, J. Leonard, B.A. Rice, B. Monks, J.A. Sawicki, Elements in the murine c-mos messenger RNA 5′-untranslated region repress translation of down-stream coding sequences, Cell Growth Diff. 7 (1996) 1415-1424.
39. J.B. Cohen, T. Unger, G. Rechavi, E. Canaani, A. Guild, Rearrangement of the oncogene c-mos in mouse myeloma, Nature 306 (1983) 797-799.
40. T. Ouchi, Y. Kurita, H. Sasai, J. Miyoshi, T. Nomura, Oncogenic activation of murine mos protein kinase by DNA rearrangements of its N-terminal coding region, Oncogene 7 (1992) 331-338.
41. G.I. Evan, T.D. Littlewood, The role of c-myc in cell growth, Curr. Opin. Genet. Dev. 3 (1993) 44-49.
42. K.B. Marcu, S.A. Bossone, A.J. Patel, myc function and regulation, Annu. Rev. Biochem. 61 (1992) 809-860.
43. S.R. Hann, M.W. King, D.L. Bentley, C.W. Anderson, R.N. Eisenman, A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas, Cell 52 (1988) 185-195.
44. S.R. Hann, M. Dixit, R.C. Sears, L. Sealy, The alternatively initiated c-myc proteins differentially regulate transcription through a noncanonical DNA-binding site, Genes Dev. 8 (1994) 2441-2452.
45. H. Saito, A.C. Hayday, K. Wiman, W.S. Hayward, S. Tonegawa, Activation of the c-myc gene by translocation: a model for translational control, Proc. Natl. Acad. Sci. USA 80 (1983) 7476-7480.
46. N.Z. Butnick, C. Miyamoto, R. Chizzonite, B.R. Cullen, G. Ju, A.M. Skalka, Regulation of the human c-myc gene: 5′ noncoding sequences do not affect translation, Mol. Cell. Biol. 5 (1985) 3009-3016.
47. N. Parkin, A. Darveau, R. Nicholson, N. Sonenberg, Cis-acting translational effects of the 5′ noncoding region of c-myc mRNA Mol, Cell. Biol. 8 (1988) 2875-2883.
48. C. Nanbru, I. Lafon, S. Audigier, M. Gensac, S. Vagner, G. Huez, A.-C. Prats, Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site, J. Biol. Chem. 272 (1997) 32061-32066.
49. M. Stoneley, F.E.M. Paulin, J.P.C. Le Quesne, S.A. Chappell, A.E. Willis, c-myc 5′ untranslated region contains an internal ribosome entry segment, Oncogene 16 (1998) 423-428.
50. T.W. Nilsen, P.A. Maroney, Translational efficiency of c-myc mRNA in Burkitt's lymphoma cells, Mol. Cell. Biol. 4 (1984) 2235-2238.
51. A. Darveau, J. Pelletier, N. Sonenberg, Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5′ untranslated region, Proc. Natl. Acad. Sci. 82 (1985) 2315-2319.
52. A. Borman, R.J. Jackson, Initiation of translation of human rhinovirus RNA: mapping the internal ribosome entry site, Virology 188 (1992) 685-696.
53. A. De Benedetti, B. Joshi, J.R. Graff, S.G. Zimmer, CHO cells transformed by the translation factor eIF4E display increased c-myc expression but require overexpression of max for tumourgenicity, Mol. Cell Diff. 2 (1994) 3447-3471.
54. S.R. Hann, Regulation and function of non-AUG-initiated proto-oncogenes, Biochimie 76 (1994) 880-886.
55. N.F. Sullivan, A.E. Willis, J.P. Moore, T. Lindahl, High levels of the c-myc protein in cell lines of Bloom's syndrome origin, Oncogene 4 (1989) 1509-1511.
56. J. German, Bloom's syndrome. Chromosome Mutation and Neoplasia, Alan Liss Inc., New York, 1983.
57. M. West, N.F. Sullivan, A.E. Willis, Translational upregulation of the c-myc oncogene in Bloom's syndrome cell lines, Oncogene 11 (1995) 2515-2524.
58. I.B. Rosenwald, A. Lazaris-Karaztas, N. Sonenberg, E.V. Smidt, Increased expression of eukaryotic initiation factors EIF4E and eIF2a in response to growth induction by c-myc, Proc. Natl. Acad. Sci. USA. 90 (1993) 6175-6178.
59. F.E.M. Paulin, M.J. West, N.F. Sullivan, A.E. Willis, Aberrant translational control of the c-myc gene in multiple myeloma, Oncogene 13 (1996) 505-513.
60. R. Niesvizky, D. Siegel, J. Michaeli, Biology and treatment of multiple myeloma, Blood Rev. 7 (1993) 24-33.
61. D.G. Gospodarowicz, G. Neufeld, D.F. Summers, Fibroblast growth factor, Mol. Cell. Endocrinol. 46 (1986) 187-204.
62. A. Wellstein, M.E. Lippman, Molecular foundations of oncology. S. Broder (Ed.). Williams & Wilkins, Baltimore, MD, 1991.
63. H. Prats, M. Kaghad, A.-C. Prats, M. Klagsburn, J.M. Lelias, P. Liauzun, P. Chalon, J.P. Tauber, F. Alamaric, J.A. Smith, D. Caput, High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons, Proc. Natl. Acad. Science (USA) 86 (1989) 1836-1840.
64. A.-C. Prats, S. Vagner, H. Prats, F. Amalric, Cis-acting elements involved in the alternative translation initiation process of human basic fibroblast growth factor mRNA, Mol. Cell. Biol. 12 (1992) 4796-4805.
65. B. Bugler, F. Almaric, H. Prats, Alternative initiation of translation determines cytoplasmic or nuclear localisation of basic fibroblast growth factor, Mol. Cell. Biol. 11 (1991) 573-577.
66. V. Patry, B. Bugler, A. Maret, M. Potier, H. Prats, Endogenous basic fibroblast growth factor isoforms involved in different intracellular protein complexes. Biochem. J. 326 (1997) 259-264.
67. D.R. Brigstock, J. Sasse, M. Klagsbrun, Subcellular distribution of basic fibroblast growth factor in human hepatoma cells, Growth Factors 4 (1991) 189-196.
68. S. Vagner, M.-C. Gensac, A. Maret, F. Bayard, F. Amalric, H. Prats, A.-C. Prats, Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes, Mol. Cell. Biol. 15 (1995) 35-44.
69. V. Kerekatte, K. Smiley, B. Hu, A. Smith, F. Gelder, A. De Benedetti, Int. J. Cancer 64 (1995) 27-31.
70. C.D. Rao, M. Pech, K.C. Robbins, S.A. Aaronson, The 5′ untranslated region of the c-sis/PDGF-2 transcript is a potent translational inhibitor, Mol. Cell. Biol. 8 (1988) 284-292.
71. P. Hovarth, A. Suganuma, M. Inaba, Y.B. Pan, K. Gupta, Cell Growth Diff. 6 (1995) 1103-1110.
72. J. Bernstein, I. Shefler, O. Elroy-Stein, The translational repression mediated by the PGGF-2/c-sis mRNA is relieved during megakaryocytic differentiation, J. Biol. Chem. 270 (1995) 10559-10565.
73. J. Bernstein, O. Sella, S. Le, O. Elroy-Stein, PDGF/c-sis mRNA leader contains a differentiation-linked internal ribosomal entry site (D-IRES), J. Biol. Chem. 272 (1997) 9356-9362.
74. C.J. Saris, J. Domen, A. Berns, The pim-1 oncogene encodes two related serine/threonine kinases by alternative initiation at AUG and CUG, EMBO J. 10 (1991) 655-664.
75. D.S. Hoover, D.G. Wingett, J. Zhang, R. Reeves, N.S. Magnuson, Pim-1 protein expression is regulated by its 5′-untranslated region and translation initiation factor elF4E, Cell Growth Diff. 8 (1997) 1371-1380.
76. T. Fukuchi-Shumugori, I. Ishii, K. Kasiwagik, H. Mashiba, H. Ekimoto, K. Igarashi, Malignant transformation by overproduction of translation factor eIF4G, Cancer Res. 57 (1997) 50411-50444.
77. N. Brass, D. Heckeld, U. Shinu, N. Pfrendschih, E. Meese, Translation initiation factor eIF4G is encoded by an amplified gene and induces an immune response in Ig gene conversion, Hum. Mol. Genet. 6 (1997) 33-39.